Holocene Advisors
AGN

Holocene Advisors’s Allergan plc AGN Stock Holding History

Holocene Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$8.86M – 850
2020
Q1 		$8.86M Buy
+50,000
New +$9.41M 0.1% 160
2018
Q2 		– Sell
-1,511
Closed -$254K – 787
2018
Q1 		$254K Sell
1,511
-3,793
-72% -$636K 0.01% 436
2017
Q4 		$868K Buy
+5,304
New +$952K 0.02% 229

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Holocene Advisors's AGN Position: Q2 2020 in Review

Holocene Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 50,000 shares — an estimated $8.86M sold.

Holocene Advisors first reported a position in AGN in Q4 2017 and held it in 3 quarters. The position peaked at $8.86M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Holocene Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Holocene Advisors sold 50,000 Allergan plc shares in Q2 2020, an estimated $8.86M.
  • Holocene Advisors first reported a position in Allergan plc in Q4 2017 and held it in 3 quarters.
  • Holocene Advisors's Allergan plc position peaked at $8.86M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Holocene Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.